Two cases of annular acute generalized exanthematous pustulosis induced by terbinafine

Eur J Dermatol. 2018 Apr 1;28(2):236-238. doi: 10.1684/ejd.2017.3199.

Authors

Stéphanie Olivier¹, Laurence De Montjoye¹, Isabelle Tromme¹, Marie Baeck¹

Affiliation

¹ Department of Dermatology, Cliniques Universitaires Saint-Luc & Pôle Pneumologie, ORL et Dermatologie Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, 1200 Brussels, Belgium.

PMID: 29336314
DOI: 10.1684/ejd.2017.3199

No abstract available

Publication types

Case Reports

MeSH terms

Acute Generalized Exanthematous Pustulosis / drug therapy
Acute Generalized Exanthematous Pustulosis / etiology*
Acute Generalized Exanthematous Pustulosis / pathology
Adrenal Cortex Hormones / therapeutic use
Adult
Antifungal Agents / adverse effects*
Antifungal Agents / therapeutic use
Biopsy, Needle
Drug Eruptions / etiology
Drug Eruptions / pathology
Female
Follow-Up Studies
Humans
Immunohistochemistry
Male
Onychomycosis / diagnosis
Onychomycosis / drug therapy*
Terbinafine / adverse effects*
Terbinafine / therapeutic use
Treatment Outcome
Withholding Treatment

Substances

Adrenal Cortex Hormones
Antifungal Agents
Terbinafine